外傷性脳損傷バイオマーカー市場、規模、シェア、動向、産業分析レポート：タイプ別、サンプルタイプ別、用途別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、世界の外傷性脳損傷（TBI）バイオマーカー市場規模は2034年までに60億5,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

外傷性脳損傷（TBI）バイオマーカー市場は、外力による脳損傷の評価と管理に役立つ生物学的指標の開発と利用に重点を置いています。タンパク質や代謝産物などの神経バイオマーカー物質は、血液、脳脊髄液、尿などの体液中で測定されます。その目的は、TBIの有無、重症度、潜在的転帰に関する客観的な情報を提供し、初期診断から長期モニタリングに至るまで、臨床医が患者のケアについて十分な情報に基づいた意思決定を行うのを支援することです。

市場概要によると、いくつかの重要な要因によって、これらの高度な診断ツールに対する需要が高まっていることがわかる。事故や転倒など、さまざまな原因によるTBIの世界の発生率の上昇により、より優れた評価方法に対する継続的なニーズが生まれています。さらに、現在進行中の調査と技術の進歩により、より正確で新しいバイオマーカーが常に特定され、その検出がより迅速かつ利用しやすくなっています。非侵襲的で迅速かつ正確な診断ソリューションに対するこのような需要は、ヘルスケアプロバイダーがTBIが象徴する公衆衛生上の広範な課題を管理する効率的な方法を模索する中で、市場を大きく形成しています。

外傷性脳損傷バイオマーカー市場レポート・ハイライト

バイオマーカーの種類別では、タンパク質バイオマーカーがTBIの診断に有効であることが確立され、技術的進歩により容易に検出できるようになったため、2024年にはタンパク質バイオマーカー分野が最大のシェアを占める。

サンプルの種類別では、非侵襲的で採取が容易であり、緊急時に重要な結果を迅速に得られる血液ベースのバイオマーカー分野が2024年に最大シェアを占めました。

用途別では、診断分野が2024年に最大シェアを占めました。受傷時に正確なTBIの同定が重要かつ緊急に必要とされるためです。

エンドユース別では、病院・診療所が2024年に最大シェアを占めました。病院・診療所は、早急な治療が必要なTBI患者の主な窓口だからです。

北米は2024年の世界市場で最大のシェアを占めました。アジア太平洋地域の外傷性脳損傷バイオマーカー市場は、予測期間中に最も急速に成長すると予測されています。

同市場の主要企業には、Abbott Laboratories, Inc.（Roche Diagnostics GmbH）、Bio-Rad Laboratories, Inc.、Siemens Healthineers AG、Quanterix、Banyan Biomarkers, Inc.、Thermo Fisher Scientific Inc.、Johnson &Johnson Services, Inc.、DRG Diagnostics GmbH、BrainScope Company, Inc.

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の外傷性脳損傷バイオマーカー市場の洞察

• 市場スナップショット
• 外傷性脳損傷バイオマーカー市場力学
  • 促進要因と機会
    • 外傷性脳損傷の発生率の上昇
    • バイオマーカーの発見と技術の進歩
  • 抑制要因と課題
    • 高い変動性と標準化の欠如
• PESTEL分析
• 外傷性脳損傷バイオマーカー市場動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の外傷性脳損傷バイオマーカー市場：タイプ別

• 主な調査結果
• イントロダクション
• タンパク質バイオマーカー
• 遺伝子バイオマーカー
• メタボロミクスバイオマーカー

第6章 世界の外傷性脳損傷バイオマーカー市場：サンプルタイプ別

• 主な調査結果
• イントロダクション
• 血液ベース
• 脳脊髄液（CSF）ベース
• 尿ベース

第7章 世界の外傷性脳損傷バイオマーカー市場：用途別

• 主な調査結果
• イントロダクション
• 診断
• 予後
• 治療反応のモニタリング

第8章 世界の外傷性脳損傷バイオマーカー市場：最終用途別

• 主な調査結果
• イントロダクション
• 病院と診療所
• 診断検査室
• 建設機関

第9章 世界の外傷性脳損傷バイオマーカー市場：地域別

• 主な調査結果
• イントロダクション
  • 外傷性脳損傷バイオマーカー市場分析：地域別、2020年～2034年
• 北米
  • 北米：タイプ別、2020～2034年
  • 北米：サンプルタイプ別、2020～2034年
  • 北米：用途別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：タイプ別、2020～2034年
  • 欧州：サンプルタイプ別、2020～2034年
  • 欧州：用途別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：タイプ別、2020～2034年
  • アジア太平洋地域：サンプルタイプ別、2020～2034年
  • アジア太平洋地域：用途別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：タイプ別、2020～2034年
  • 中東・アフリカ：サンプルタイプ別、2020～2034年
  • 中東・アフリカ：用途別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：タイプ別、2020-2034年
  • ラテンアメリカ：サンプルタイプ別、2020～2034年
  • ラテンアメリカ：用途別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Abbott Laboratories, Inc.
• Banyan Biomarkers, Inc.
• Bio-Rad Laboratories, Inc.
• BrainScope Company, Inc.
• DRG Diagnostics GmbH
• F. Hoffmann-La Roche Ltd.（Roche Diagnostics GmbH）
• Johnson & Johnson Services, Inc.
• Quanterix
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

List of Tables:

• Table 1 Global Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 2 Global Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 3 Global Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 4 Global Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 5 North America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 6 North America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 7 North America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 8 North America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 9 U.S.: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 10 U.S.: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 11 U.S.: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 12 U.S.: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 13 Canada: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 14 Canada: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 15 Canada: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 16 Canada: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 17 Europe: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 18 Europe: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 19 Europe: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 20 Europe: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 21 UK: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 22 UK: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 23 UK: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 24 UK: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 25 France: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 26 France: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 27 France: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 28 France: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 29 Germany: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 30 Germany: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 31 Germany: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 32 Germany: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 33 Italy: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 34 Italy: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 35 Italy: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 36 Italy: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 37 Spain: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 38 Spain: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 39 Spain: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 40 Spain: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 41 Netherlands: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 42 Netherlands: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 43 Netherlands: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 44 Netherlands: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 45 Russia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 46 Russia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 47 Russia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 48 Russia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 57 China: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 58 China: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 59 China: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 60 China: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 61 India: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 62 India: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 63 India: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 64 India: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 65 Malaysia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 66 Malaysia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 67 Malaysia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 68 Malaysia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 69 Japan: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 70 Japan: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 71 Japan: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 72 Japan: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 73 Indonesia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 74 Indonesia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 75 Indonesia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 76 Indonesia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 77 South Korea: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 78 South Korea: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 79 South Korea: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 80 South Korea: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 81 Australia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 82 Australia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 83 Australia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 84 Australia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 97 UAE: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 98 UAE: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 99 UAE: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 100 UAE: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 101 Israel: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 102 Israel: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 103 Israel: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 104 Israel: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 105 South Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 106 South Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 107 South Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 108 South Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 113 Latin America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 114 Latin America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 115 Latin America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 116 Latin America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 117 Mexico: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 118 Mexico: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 119 Mexico: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 120 Mexico: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 121 Brazil: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 122 Brazil: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 123 Brazil: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 124 Brazil: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 125 Argentina: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 126 Argentina: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 127 Argentina: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 128 Argentina: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Traumatic Brain Injury Biomarkers Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Type
• Figure 7. Global Traumatic Brain Injury Biomarkers Market, by Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Sample Type
• Figure 9. Global Traumatic Brain Injury Biomarkers Market, by Sample Type, 2024 & 2034 (USD Billion)
• Figure 10. Market by Application
• Figure 11. Global Traumatic Brain Injury Biomarkers Market, by Application, 2024 & 2034 (USD Billion)
• Figure 12. Market by End Use
• Figure 13. Global Traumatic Brain Injury Biomarkers Market, by End Use, 2024 & 2034 (USD Billion)

According to a new study by Polaris Market Research, the global traumatic brain injury (TBI) biomarkers market size is expected to reach USD 6.05 billion by 2034. The report "Traumatic Brain Injury Biomarkers Market Size, Share, Trends, & Industry Analysis Report By Type (Protein Biomarkers, Genetic Biomarkers, and Metabolomic Biomarkers), By Sample Type, By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The traumatic brain injury (TBI) biomarkers market focuses on developing and using biological indicators to help assess and manage brain injuries caused by external forces. These neuro biomarker substances, such as proteins or metabolites, are measured in bodily fluids such as blood, cerebrospinal fluid, and urine. The goal is to provide objective information about the presence, severity, and potential outcomes of a TBI, supporting clinicians in making informed decisions about patient care, from initial diagnosis to long-term monitoring.

The market overview reveals a growing demand for these advanced diagnostic tools, driven by several key factors. The rising global incidence of TBIs from various causes, such as accidents and falls, creates a continuous need for better assessment methods. Moreover, ongoing research and technological advancements are constantly identifying new and more precise biomarkers, making their detection faster and more accessible. This demand for noninvasive, rapid, and accurate diagnostic solutions is significantly shaping the market, as healthcare providers seek efficient ways to manage the widespread public health challenge that TBI represents.

Traumatic Brain Injury Biomarkers Market Report Highlights:

By type, the protein biomarkers segment held the largest share in 2024 due to their established effectiveness in diagnosing TBI and technological advancements that make them easy to detect.

Based on sample type, the blood-based biomarkers segment held the largest share in 2024 as they are noninvasive and easy to collect, providing quick results crucial for emergencies.

In terms of application, the diagnosis segment held the largest share in 2024, as there is a critical and immediate need for accurate TBI identification upon injury.

By end use, the hospitals and clinics segment held the largest share in 2024 since they are the primary points of contact for TBI patients requiring immediate medical attention.

North America held the largest share in the global market in 2024. The Asia Pacific traumatic brain injury biomarkers market is projected to grow fastest during the forecast period.

A few key players in the market include Abbott Laboratories, Inc.; F. Hoffmann-La Roche Ltd. (Roche Diagnostics GmbH); Bio-Rad Laboratories, Inc.; Siemens Healthineers AG; Quanterix; Banyan Biomarkers, Inc.; Thermo Fisher Scientific Inc.; Johnson & Johnson Services, Inc.; DRG Diagnostics GmbH; and BrainScope Company, Inc.

Polaris Market Research has segmented the traumatic brain injury biomarkers market report on the basis of type, sample type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

Protein Biomarkers

Genetic Biomarkers

Metabolomic Biomarkers

By Sample Type Outlook (Revenue - USD Billion, 2020-2034)

Blood-Based

Cerebrospinal Fluid (CSF)-Based

Urine-Based

By Application Outlook (Revenue - USD Billion, 2020-2034)

Diagnosis

Prognosis

Monitoring Treatment Response

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Clinics

Diagnostic Laboratories

Research Institutes

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Traumatic Brain Injury Biomarkers Market Insights

• 4.1. Traumatic Brain Injury Biomarkers Market - Market Snapshot
• 4.2. Traumatic Brain Injury Biomarkers Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Incidence of Traumatic Brain Injuries
    • 4.2.1.2. Advancements in Biomarker Discovery and Technology
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High variability and lack of standardization
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Traumatic Brain Injury Biomarkers Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Traumatic Brain Injury Biomarkers Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
• 5.3. Protein Biomarkers
  • 5.3.1. Global Traumatic Brain Injury Biomarkers Market, by Protein Biomarkers, by Region, 2020-2034 (USD Billion)
• 5.4. Genetic Biomarkers
  • 5.4.1. Global Traumatic Brain Injury Biomarkers Market, by Genetic Biomarkers, by Region, 2020-2034 (USD Billion)
• 5.5. Metabolomic Biomarkers
  • 5.5.1. Global Traumatic Brain Injury Biomarkers Market, by Metabolomic Biomarkers, by Region, 2020-2034 (USD Billion)

6. Global Traumatic Brain Injury Biomarkers Market, by Sample Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
• 6.3. Blood-based
  • 6.3.1. Global Traumatic Brain Injury Biomarkers Market, by Blood-based, by Region, 2020-2034 (USD Billion)
• 6.4. Cerebrospinal fluid (CSF)-based
  • 6.4.1. Global Traumatic Brain Injury Biomarkers Market, by Cerebrospinal fluid (CSF)-based, by Region, 2020-2034 (USD Billion)
• 6.5. Urine-based
  • 6.5.1. Global Traumatic Brain Injury Biomarkers Market, by Urine-based, by Region, 2020-2034 (USD Billion)

7. Global Traumatic Brain Injury Biomarkers Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 7.3. Diagnosis
  • 7.3.1. Global Traumatic Brain Injury Biomarkers Market, by Diagnosis, by Region, 2020-2034 (USD Billion)
• 7.4. Prognosis
  • 7.4.1. Global Traumatic Brain Injury Biomarkers Market, by Prognosis, by Region, 2020-2034 (USD Billion)
• 7.5. Monitoring treatment response
  • 7.5.1. Global Traumatic Brain Injury Biomarkers Market, by Monitoring treatment response, by Region, 2020-2034 (USD Billion)

8. Global Traumatic Brain Injury Biomarkers Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• 8.3. Hospitals & Clinics
  • 8.3.1. Global Traumatic Brain Injury Biomarkers Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
• 8.4. Diagnostic Laboratories
  • 8.4.1. Global Traumatic Brain Injury Biomarkers Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
• 8.5. Research Institutes
  • 8.5.1. Global Traumatic Brain Injury Biomarkers Market, by Research Institutes, by Region, 2020-2034 (USD Billion)

9. Global Traumatic Brain Injury Biomarkers Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Traumatic Brain Injury Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Traumatic Brain Injury Biomarkers Market - North America
  • 9.3.1. North America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  • 9.3.3. North America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.3.4. North America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.5. Traumatic Brain Injury Biomarkers Market - US
    • 9.3.5.1. US: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.6. Traumatic Brain Injury Biomarkers Market - Canada
    • 9.3.6.1. Canada: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• 9.4. Traumatic Brain Injury Biomarkers Market - Europe
  • 9.4.1. Europe: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.5. Traumatic Brain Injury Biomarkers Market - UK
    • 9.4.5.1. UK: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.6. Traumatic Brain Injury Biomarkers Market - France
    • 9.4.6.1. France: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.7. Traumatic Brain Injury Biomarkers Market - Germany
    • 9.4.7.1. Germany: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.8. Traumatic Brain Injury Biomarkers Market - Italy
    • 9.4.8.1. Italy: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.9. Traumatic Brain Injury Biomarkers Market - Spain
    • 9.4.9.1. Spain: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.10. Traumatic Brain Injury Biomarkers Market - Netherlands
    • 9.4.10.1. Netherlands: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.11. Traumatic Brain Injury Biomarkers Market - Russia
    • 9.4.11.1. Russia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.12. Traumatic Brain Injury Biomarkers Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• 9.5. Traumatic Brain Injury Biomarkers Market - Asia Pacific
  • 9.5.1. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.5. Traumatic Brain Injury Biomarkers Market - China
    • 9.5.5.1. China: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.6. Traumatic Brain Injury Biomarkers Market - India
    • 9.5.6.1. India: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.7. Traumatic Brain Injury Biomarkers Market - Malaysia
    • 9.5.7.1. Malaysia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.8. Traumatic Brain Injury Biomarkers Market - Japan
    • 9.5.8.1. Japan: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.9. Traumatic Brain Injury Biomarkers Market - Indonesia
    • 9.5.9.1. Indonesia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.10. Traumatic Brain Injury Biomarkers Market - South Korea
    • 9.5.10.1. South Korea: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.11. Traumatic Brain Injury Biomarkers Market - Australia
    • 9.5.11.1. Australia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.12. Traumatic Brain Injury Biomarkers Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• 9.6. Traumatic Brain Injury Biomarkers Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.5. Traumatic Brain Injury Biomarkers Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.6. Traumatic Brain Injury Biomarkers Market - UAE
    • 9.6.6.1. UAE: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.7. Traumatic Brain Injury Biomarkers Market - Israel
    • 9.6.7.1. Israel: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.8. Traumatic Brain Injury Biomarkers Market - South Africa
    • 9.6.8.1. South Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.9. Traumatic Brain Injury Biomarkers Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
• 9.7. Traumatic Brain Injury Biomarkers Market - Latin America
  • 9.7.1. Latin America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.5. Traumatic Brain Injury Biomarkers Market - Mexico
    • 9.7.5.1. Mexico: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.6. Traumatic Brain Injury Biomarkers Market - Brazil
    • 9.7.6.1. Brazil: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.7. Traumatic Brain Injury Biomarkers Market - Argentina
    • 9.7.7.1. Argentina: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.8. Traumatic Brain Injury Biomarkers Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Sample Type, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Traumatic Brain Injury Biomarkers Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories, Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Banyan Biomarkers, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Bio-Rad Laboratories, Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. BrainScope Company, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. DRG Diagnostics GmbH
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. F. Hoffmann-La Roche Ltd. (Roche Diagnostics GmbH)
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Johnson & Johnson Services, Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Quanterix
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Siemens Healthineers AG
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Thermo Fisher Scientific Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development